Ruti Aga and the Six-Year Ban: When a Fake Prescription Outweighs the Doping Offence
**Câu trả lời cốt lõi** Ruti Aga, 32 tuổi, vận động viên marathon người Ethiopia, bị Athletics Integrity Unit cấm thi đấu sáu năm từ ngày 10 tháng 9: hai năm do mẫu thử dương tính methylprednisolone và bốn năm do làm giả đơn thuốc. Hai án thi hành nối tiếp theo Bộ luật Phòng chống doping thế giới. **Dữ kiện chính** - Aga vô địch Tokyo Marathon 2019 và ba lần về nhì tại các World Marathon Majors. - Methylprednisolone là glucocorticoid tổng hợp nhóm S9, chỉ bị cấm trong thi đấu, thuộc diện Specified Substance. - Đơn thuốc do một người họ hàng ký, không có đăng ký hành nghề, trên cuống sổ của phòng khám không tồn tại. - Án bốn năm cho hành vi làm giả lớn hơn án hai năm cho chất cấm. - Aga trở lại hợp lệ ở tuổi khoảng 38; kết quả giải bán marathon tại Trung Quốc tháng 3 bị hủy. **Nguồn** Athletics Integrity Unit (AIU), công bố ngày 10 tháng 9; năm không được nêu trong thông cáo gốc. **Hỏi đáp liên quan** Hỏi: Vì sao án của Ruti Aga lên tới sáu năm? Đáp: Vì hai hành vi vi phạm — có chất cấm trong mẫu thử và làm giả bằng chứng — được thi hành nối tiếp: hai năm cộng bốn năm. Hỏi: Methylprednisolone có phải steroid đồng hóa không? Đáp: Không, đây là glucocorticoid tổng hợp nhóm S9, chỉ bị cấm trong thời gian thi đấu và thuộc diện Specified Substance. Hỏi: Aga còn cơ hội trở lại thi đấu không? Đáp: Cô đủ điều kiện trở lại ở tuổi khoảng 38 sau sáu năm nghỉ, nên khả năng trở lại nhóm dẫn đầu marathon gần như không còn.
A clinic that does not exist. A prescription written on an old pad from a former workplace, whose owner confirmed the signatory had never set foot there. A relative listed as the doctor, holding no medical registration number. Those three pieces, added together, cost far more than the methylprednisolone positive that started the story.
The Athletics Integrity Unit, World Athletics' independent integrity body, announced on 10 September: Ruti Aga, a 32-year-old Ethiopian marathon runner, is banned for six years. Two years for the presence of a prohibited substance in her sample. Four years for tampering with documentation. The sanctions are served consecutively, not concurrently.
The scoreboard ends the match, but most of the story sits beneath it. Here the scoreboard reads “six years”; the story sits in a folder of paperwork that nobody in Aga's family priced correctly.

Context
Aga is not a vague name. In 2026 she won the Tokyo Marathon, one of the six largest road races in the system. She has three runner-up finishes at World Marathon Majors. Across the 2026–2026 window she belonged to the elite tier of women's marathon running, not the fringe.
In March she won a half marathon in China. The statement discloses no time. That detail is worth pausing on: a road-racing win in Asia by an East African athlete typically belongs to the appearance-fee circuit, where testing density is far lower than at a world championship, and where income is set by invitation contracts rather than by results tables.
Then came the positive test. Aga explained she was treating a knee injury. Her team submitted a prescription to prove a legitimate route of administration. The AIU checked it the standard way: a direct call to the clinic, a registration lookup, a cross-check with the former employer. Nothing matched.
People remember the goals; I remember the legs drained after the whistle. In this file, what I remember is a single sheet of paper dissected line by line over a few weeks.

Analysis
Read the architecture of the sanction before reading the public reaction.
Under the World Anti-Doping Code, when an athlete commits multiple violations, the sanctions run consecutively rather than concurrently. Aga had two: presence of a prohibited substance, and tampering with evidence during results management. The baseline for the first is two years. The baseline for the second is four. Six in total.
The analytically significant point is that four is larger than two: the system prices the cover-up at twice the price of the substance. That is a deliberate policy choice, not an accidental sum.
Then comes the part international media mislabelled. Methylprednisolone is not an anabolic steroid. It is a synthetic glucocorticoid, a corticosteroid, sitting in WADA class S9, prohibited in-competition only, and classified as a Specified Substance — a category recognised as more plausibly linked to inadvertent or therapeutic use. Calling it a steroid inflates the perceived severity for general readers while obscuring a fact: the substance side of this file was always the softer half.
Had Aga held a valid Therapeutic Use Exemption for the knee injection, and had the route of administration complied outside competition, the scenario could have been no violation at all, or two years with an accepted therapeutic argument. There was no exemption. There was fabrication. The result was six years.
I have watched enough Asian road races to know one thing about the East African racing circuit: most athletes in its middle tier have no dedicated integrity lawyer, no compliance officer, and handle medical paperwork through relatives or brokers. A support structure that thin turns a small error at the proof stage into an independent integrity violation.
The AIU's evidence has no gaps. The clinic confirmed the prescription was not theirs. The registry confirmed the signatory held no practising certificate. The former employer confirmed the person had never been staff. Three independent sources, three denials, all pointing the same way. A chain like that closes the “misunderstanding” argument almost completely.
On age: Aga is 32. For women's marathoners the peak window commonly extends past 35. Her ban runs from 10 September, which puts eligibility return at roughly 38. Six years is longer than the entire span from her arrival in the elite tier to her suspension.
On money: the March half marathon result is almost certainly annulled, prize money included. Six years without World Marathon Majors invitations means six years without the core revenue of a top-tier marathoner: appearance fees, prize money, representation contracts. For a 32-year-old, this is not a suspended sentence. It is a terminal one.
Contrarian angle
There is a reading I consider wrong, and it will travel fast.
The first wrong reading: “another Ethiopian doper”. Ethiopia's marathon pipeline is so deep that one individual leaving the system barely moves national results — and precisely for that reason, there is no basis for inferring a doping system from one case. The details in the file point the opposite way from an organised scheme: they are clumsy. An invented clinic. An old prescription pad. A family member. Organised schemes do not operate like this.
The second wrong reading: merging two violations into one. With only the positive, the story is an athlete who treated a knee badly. Add the fabrication, and the story becomes an integrity case. The two have very different consequences, and the second will live far longer in the memory of the public, the sponsors and the race organisers.
The third wrong reading: treating six years as the sporting sentence. The commercial sentence is the real one. A glucocorticoid positive can be retold as a therapeutic misadventure. A fake prescription from a non-existent clinic cannot. Morality clauses in sponsorship contracts tend to be invoked in exactly these situations, and they do not wait for a final ruling.
They told me girls do not understand tactics; I write so they have to read again. This time the tactics were not on the track. They were in a folder of paperwork, and Aga lost there before she could run again.
Takeaway
There is one unresolved detail, and I want to leave it unresolved: the source does not state the route of administration for methylprednisolone, nor the year of the positive test. If it was an intra-articular injection close to competition, the in-competition prohibition is triggered exactly as written, and the therapeutic story becomes far more plausible than the way it is currently being told.
What is worth keeping from this file sits in the structure, not in the substance: a person who runs 42.195 kilometres alone still needs a team behind her — someone who reads the paperwork, someone who knows when to disclose, someone who knows a late-filed exemption still beats a prescription filed from a clinic that does not exist.
214 days without competition taught me to listen to the pulse of persistence. Six years is no longer persistence. It is a silence long enough for people to forget a champion, and long enough for a hard question to stay: when a system punishes the cover-up at twice the price of the offence, is it protecting the truth, or teaching athletes that early confession is a mandatory survival skill of the professional game?
